Company intelligence / Profile preview

Nephros

South Orange, New Jersey, United Statesnephros.com ↗

Ownership: Public · NEPH
Development stage: Commercial

Overview

Nephros has developed proprietary hollow-fiber water filtration technology capable of retaining bacteria, viruses, and endotoxins. Their filters are FDA Class II cleared for infection control use in healthcare facilities and dialysis centers. The company has demonstrated strong revenue growth with significant adoption across hospitals since pivoting to infection control solutions.

Therapeutic areas: Infectious Diseases
Modalities: DeviceDiagnostic
Industry: Therapeutic Medical Devices

Partnerships

Focus is on direct sales to hospitals/healthcare systems

Financials

Market cap: $47.3M
Total revenue: $6M
Enterprise value: $43.5M

Beyond the preview

Go deeper on Nephros.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nephros.

Explore the full profile